Skip to main content
OnPoint Now
PoliticsUnited States and China

Trump’s Tariff Threat: A Risky Move in the Fentanyl Fight Against China

President-elect Donald J. Trump’s proposal to impose tariffs on China to tackle the fentanyl crisis may jeopardize ongoing cooperation in narcotics control.

By David PiersonSource: nytimes.com1 min read
Trump’s Tariff Threat: A Risky Move in the Fentanyl Fight Against China
Image via nytimes.com

In brief

While President-elect Donald J. Trump's proposed tariffs on China aim to curb the influx of the opioid fentanyl, experts warn that this strategy could undermine crucial anti-narcotics cooperation that has seen recent progress.

In a stark political maneuver, President-elect Donald J. Trump has threatened to levy new tariffs on China, citing the ongoing fentanyl crisis in the United States as a primary motivator. This strategy has raised concerns among experts regarding the potential consequences for U.S.-China cooperation in combating drug trafficking, particularly the flow of synthetic opioids produced from Chinese chemicals.During Trump's previous term, the U.S. and China made strides towards collaborating on narcotics enforcement; however, this cooperation dwindled amidst escalating trade tensions and geopolitical conflicts. Despite the friction, there were glimmers of progress as recently as September, when Chinese authorities broadened their oversight on precursor chemicals critical for fentanyl synthesis. This change followed high-profile talks between President Biden and Chinese President Xi Jinping, signaling a rare moment of joint effort against narcotics.Fentanyl streaming into the U.S. largely originates from Mexican drug cartels that utilize precursors sourced from China. The alarming rise in opioid-related deaths, reaching tens of thousands annually, underscores the urgency of addressing this public health crisis. Experts emphasize that the illicit production community in China poses significant challenges, as manufacturers can constantly evolve their processes, often sidestepping existing regulations by creating new, unregulated chemicals.The mood among analysts is one of caution. Tariffs are unlikely to genuinely stem the flow of fentanyl and may indeed damage the fragile counternarcotics partnerships currently in place. Vanda Felbab-Brown, a senior fellow at the Brookings Institution, pointed out that implications of hitting China economically could unravel the existing cooperative framework built over the last year—especially after a nearly two-year absence of collaboration.Going forward, experts argue that both U.S. and Chinese law enforcement need more robust collaboration, particularly in anti-money laundering initiatives aimed at curtailing the financial routes that sustain narcotics trafficking. While the U.S. government seeks aggressive tactics like tariffs, the complexities of the fentanyl crisis suggest a more nuanced approach may be required to navigate the entwined issues of drugs and diplomacy.

Topics

More on this story